Adriamycin Cancer Drug

The U.S. Food and Drug Administration approved Adriamycin® (doxorubicin hydrochloride) to treat certain types of cancer, namely ovarian, breast, and lung cancers. This drug belongs to the anthracycline class and is given by injection in a healthcare provider's office.
 
As with any chemotherapy drug for cancer, Adriamycin can cause certain side effects, such as hair loss, nausea, and vomiting. Various factors will affect the dose your healthcare provider recommends, including the type of cancer that is being treated and your height and weight.
 
(To learn more about this cancer drug, click Adriamycin. Topics discussed in this article include how it works, what to do if you are pregnant or breastfeeding, generic availability, and more.)
 

Adriamycin Cancer Drug

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.